Seelos Therapeutics Inc (SEEL)

[Boneride]

iAnthus is almost at a 52-week low now with 8 buy ratings and a $12.21 price target. If you don't mind waiting, there's a triple for ya. GTBIF a big American dope company I like as well. We've all seen all the hopelessly addicted alcoholics and druggie/dope heads zombie-ing around so, to me, this is like handing us cash on a silver platter. In the middle of the next administration, my guess is it'll all be legal. But watch for those partnerships in the meantime. SEEL will rebound as well. I don't think it can tank forever.